Pharmacological therapy is only part of the answer to improving mental health
Summary of the issues surrounding psychotropic drug use in residential aged care facilities (RACFs)
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
We thank Daniel O’Connor, Roderick McKay and Gerard Byrne, executive members of the Faculty of Psychiatry of Old Age, Royal Australian New Zealand College of Psychiatrists (RANZCP) for discussing with us the issues covered in this article.
We are both executive members of the Faculty of Psychiatry of Old Age, RANZCP. The views expressed in this article are our own and not those of the RANZCP. Stephen Macfarlane has received speaker’s honoraria from Eli Lilly, Janssen-Cilag, Pfizer and Lundbeck, and a Lundbeck Fellowship to attend a series of seminars on dementia held at the Lundbeck Institute in Skodsborg, Denmark, in 2009.